You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adult anaplastic meningioma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)

Recruiting
  • Central Nervous System Neoplasms
  • +22 more
  • Bethesda, Maryland
    National Institutes of Health
Mar 1, 2022

Meningioma, Meningioma Atypical, Anaplastic Meningioma Trial in Rome (Biological biomarker assessment)

Recruiting
  • Meningioma
  • +2 more
  • Biological biomarker assessment
  • Rome, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCCS
Mar 29, 2023

High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

Recruiting
  • High Grade Glioma
  • +12 more
  • LUTATHERA® (Lutetium Lu 177 dotatate)
  • Aurora, Colorado
  • +8 more
Jan 16, 2023

Meningioma Trial (Radiotherapy 68 Gy(RBE), Radiotherapy 72 Gy(RBE), Radiotherapy 60 Gy(RBE))

Not yet recruiting
  • Meningioma
  • Radiotherapy 68 Gy(RBE)
  • +2 more
  • (no location specified)
Aug 2, 2022

Brain Cancer Trial in United States (Optune (NovoTTF-100A))

Active, not recruiting
  • Brain Cancer
  • Optune (NovoTTF-100A)
  • Los Angeles, California
  • +8 more
Jul 1, 2022

Oncological Care for Patients With Meningioma

Recruiting
  • Atypical Meningioma
  • +5 more
    • Montpellier, France
      Uh Montpellier
    Apr 13, 2022

    Meningioma, Meningioma, Adult Trial in Saint Louis (drug, radiation, procedure)

    Active, not recruiting
    • Meningioma
    • Meningioma, Adult
    • Saint Louis, Missouri
      Washington University School of Medicine
    Sep 27, 2022

    Meningiomas Trial in Boston (Nivolumab - 240 mg, Ipilimumab - 1 mg/kg, Nivolumab - 480 mg)

    Recruiting
    • Meningiomas
    • Nivolumab - 240 mg
    • +4 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 3, 2022

    Cognition, Brain Tumor, Magnetic Resonance Imaging Trial in Gent, Leuven, Wilrijk (behavioral, diagnostic test, other)

    Not yet recruiting
    • Cognition
    • +5 more
    • Neurocognitive tests: WAIS digit span, HVLT-R, COWAT, MOCA, WAIS digit symbol substitution, TMT A&B, Stroop Color Word Test
    • +3 more
    • Gent, Belgium
    • +2 more
    Feb 3, 2023

    Anaplastic Large Cell Lymphoma, ALK-Positive, Inflammatory Myofibroblastic Tumor, Other Solid Tumor Trial in Utrecht

    Recruiting
    • Anaplastic Large Cell Lymphoma, ALK-Positive
    • +2 more
    • Paris, France
    • +1 more
    Sep 27, 2022

    Usage of Brigatinib in Treatment of Adult Approved Indications

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Anaplastic Lymphoma Kinase
    • No Intervention
    • Busan, Korea, Republic of
      Pusan National University Hospital
    Oct 19, 2022

    Brain and CNS Tumors Trial in Canada, United States (54 Gy radiotherapy, 60 Gy radiotherapy)

    Active, not recruiting
    Has Results
    • Brain and Central Nervous System Tumors
    • 54 Gy radiotherapy
    • 60 Gy radiotherapy
    • Phoenix, Arizona
    • +77 more
    Dec 15, 2022

    Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

    Not yet recruiting
    • Anaplastic Astrocytoma
    • +17 more
      • (no location specified)
      Jun 28, 2023

      Rare CNS Tumors Outcomes &Risk

      Recruiting
      • High Grade Meningioma
      • +4 more
        • Bethesda, Maryland
          National Cancer Institute (NCI)
        Jul 6, 2022

        Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Rochester (procedure,

        Active, not recruiting
        • Adult Anaplastic Astrocytoma
        • +15 more
        • biopsy
        • +7 more
        • Rochester, Minnesota
          Mayo Clinic
        Apr 8, 2022

        Meningioma Trial in Vandœuvre-lès-Nancy (Everolimus)

        Not yet recruiting
        • Meningioma
        • Vandœuvre-lès-Nancy, Grand Est, France
        • +1 more
        Nov 8, 2023

        T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

        Not yet recruiting
        • T-Cell Non-Hodgkin Lymphoma
        • +14 more
        • WU-CART-007
        • Saint Louis, Missouri
          Washington University School of Medicine
        Jan 17, 2023

        Solid Tumor, Haematological Malignancy, Melanoma Trial in United Kingdom (Vemurafenib, Cobimetinib)

        Recruiting
        • Solid Tumor
        • +11 more
        • Belfast, United Kingdom
        • +16 more
        Mar 2, 2023

        Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma Trial in Duarte (biological,

        Completed
        Has Results
        • Adult Anaplastic Astrocytoma
        • +6 more
        • E. coli CD-expressing genetically modified neural stem cells
        • +4 more
        • Duarte, California
          City of Hope Medical Center
        Sep 28, 2021

        Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Miami (biological, drug, procedure)

        Completed
        • Malignant Glioma
        • +3 more
        • Dendritic Cell Vaccine
        • +3 more
        • Miami, Florida
          University of Miami
        Jul 19, 2022

        Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed

        Not yet recruiting
        • Pediatric Cancer
        • +11 more
        • anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
        • Milwaukee, Wisconsin
          Children's Wisconsin
        Sep 14, 2022

        Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

        Active, not recruiting
        • Adult Lymphocyte Depletion Hodgkin Lymphoma
        • +16 more
        • 6,8-bis(benzylthio)octanoic acid
        • bendamustine hydrochloride
        • Winston-Salem, North Carolina
        • +1 more
        Apr 8, 2022

        Peripheral T Cell Lymphoma, PTCL, Extranodal NK/T-cell Lymphoma Trial in Worldwide (Tislelizumab)

        Completed
        Has Results
        • Peripheral T Cell Lymphoma
        • +18 more
        • Vancouver, British Columbia, Canada
        • +29 more
        Apr 29, 2022

        T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

        Recruiting
        • T-cell Lymphoma
        • +30 more
        • Optional Blood Sample
        • Optional Nail Sample
        • Duarte, California
        • +25 more
        Jul 28, 2023

        Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

        Completed
        Has Results
        • Adult Nasal Type Extranodal NK/T-cell Lymphoma
        • +20 more
        • Scottsdale, Arizona
        • +1 more
        May 6, 2022